See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday. More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.

Chemical Class · Receptor Agonist

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
12415 11-deoxy-11-methylene-15-keto Prostaglandin D2 - >98% 100.780055248619 11-deoxy-11-methylene-15-keto-prostaglandin-d2 11-deoxy-11-methylene-15-keto PGD2 prostaglandins 11-deoxy-11-methylene-15-keto-PGD2 CRTH2 receptors eosinophils stable ligands 100.780055248619
14570 11-deoxy-16,16-dimethyl Prostaglandin E2 53658-98-3 >98% 101.073425414364 11-deoxy-16-16-dimethyl-prostaglandin-e2 11-deoxy-16,16-dimethyl PGE2 11-deoxy-16,16-dimethyl-PGE2 prostaglandins agonists EP2 EP3 receptors 101.073425414364
16783 11-keto Fluprostenol - ≥98% 32.086795580110 11-keto-fluprostenol Fluprostenol Prostaglandin D2 11-keto-fluprostenol analogs DP receptors PGD2 agonists prostaglandins 32.086795580110
18212 13,14-dehydro-15-cyclohexyl Carbaprostacyclin 145375-81-1 >98% 38.551533149171 13-14-dehydro-15-cyclohexyl-carbaprostacyclin PGI2 analogs vasodilation prostaglandins 13,14-dihydro-15-cyclohexyl-carbaprostacyclin 38.551533149171
12610 13,14-dihydro-15-keto Prostaglandin D2 59894-07-4 >98% 79.064287292818 13-14-dihydro-15-keto-prostaglandin-d2 13,14-dihydro-15-keto PGD2 metabolites 13,14-dihydro-15-keto-PGD2 prostaglandins DK PGD2 diketo DKPGD2 CRTH2 DP2 79.064287292818
12700 15-deoxy-Δ12,14-Prostaglandin D2 85235-11-6 ≥95% 108.501270718232 15-deoxy-12-14-prostaglandin-d2 15-deoxy-Δ12,14-PGD2 PPARs prostaglandins peroxisome proliferator-activated receptors 15-deoxy-DELTA12,14-PGD2 15-deoxy-.DELTA.12,14-PGD2 15-deoxy-d12,14-PGD2 leukemia cells cancer 15d-pgd2 108.501270718232
18570 15-deoxy-Δ12,14-Prostaglandin J2 87893-55-8 ≥95% 87.065636974572 15-deoxy-12-14-prostaglandin-j2 15-deoxy-Δ12,14-PGJ2 PPARγ PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 nuclear receptors 15-deoxy-Δ12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands 15dpgj2 atherosclerosis 87.065636974572
10010132 15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester - ≥98% (isomer mixture) 2008-06-09 19.581055862492 15-deoxy-12-14-prostaglandin-j2-2-glycerol-ester 15-deoxy-Δ12,14-PGJ2-2-glycerol ester PPARgamma PPAR.gamma. PPARg PGD2 PGJ2 lipolysis prostaglandins adipocyte endocannabinoid metabolism diabetes obesity nuclear receptors COX-2 COX2 2-AG 2AG cannabinoids cbs synthetic 19.581055862492
10006692 (+)-15-epi Cloprostenol 54276-22-1 ≥98% 2005-05-18 6.888674033149 -15-epi-cloprostenol (+)-15(S)-Cloprostenol; D-Cloprostenol prostaglandins F2.alpha. PGF2a analogs cloprostenols FP agonists 15(S) 15-epi C-15 epimers receptors 15b 15.beta.-hydroxy enantiomers ligands isomers 6.888674033149
12720 15(R)-15-methyl Prostaglandin D2 Exclusive 210978-26-0 >95% ✓ 56.713848987108 15-r-15-methyl-prostaglandin-d2 15(R)-15-methyl PGD2 15(R)-15-methyl-PGD2 prostaglandins 15-epi-15-methyl-PGD2 15R-15-methyl-PGD2 56.713848987108
16814 15(R)-17-phenyl trinor Prostaglandin F2α 41639-71-8 ≥98% 14.761410464738 15-r-17-phenyl-trinor-prostaglandin-f2 15(R)-17-phenyl trinor PGF2α; 15(R)-Bimatoprost (free acid); 15-epi Bimatoprost (free acid) prostaglandins 15(R)-17-phenyl-trinor-PGF2.alpha. unnatural isomers FP 15(R)-17-phenyl-trinor-PGF2alpha receptors agonists 15-epi-17-phenyl-trinor-PGF2alpha 15-epi-17-phenyl-trinor-PGF2.alpha. 15R-17-phenyl-trinor-PFG2.alpha. 15R-17-phenyl-trinor-PFG2alpha 14.761410464738
10118 15(R)-Prostaglandin D2 - >98% 55.512154696132 15-r-prostaglandin-d2 15(R)-PGD2 PGD2 vasodilation prostaglandins 15(R)-PGD2 15-epi-PGD2 15R-PGD2 DP2 receptors agonists CRTH2 endogenous 15d-pgj2 55.512154696132
12730 15(S)-15-methyl Prostaglandin D2 85280-90-6 >95% 53.872375690607 15-s-15-methyl-prostaglandin-d2 15(S)-15-methyl PG2 15(S)-15-methyl-PGD2 prostaglandins vasoconstriction analogs 15S-15-methyl-PGD2 53.872375690607
16743 15(S)-15-methyl Prostaglandin F2α 35700-23-3 >98% 11.466220994474 15-s-15-methyl-prostaglandin-f2 U-32921; Carboprost; 15(S)-15-methyl PGF2α 15(S)-15-methyl-PGF2alpha 15(S)-15-methyl-PGF2.alpha. analogs 15S-15-methyl-PGF2alpha 15S-15-methyl-PGF2.alpha. 11.466220994474
16750 16,16-dimethyl Prostaglandin F2α 39746-23-1 >98% 49.602928176796 16-16-dimethyl-prostaglandin-f2 16,16-dimethyl PGF2α prostaglandins 16,16-dimethyl-PGF2.alpha. 16,16-dimethyl-PGF2alpha analogs FP receptors 49.602928176796
10991 16(R)-AFP 07 (free acid) Exclusive 773525-80-2 ≥98% ✓ 2011-08-16 26.645999999999 16-r-afp-07-free-acid prostaglandins I2 PGI2 prostacyclin IP receptors agonists EP1 EP2 EP3 EP4 AH 23848 PGs prostacyclin AFP-07 AFP07 EP prostanoids 26.645999999999
10010839 17-phenoxy trinor Prostaglandin F2α - >98% 2008-02-04 2.405237569060 17-phenoxy-trinor-prostaglandin-f2 17-phenoxy trinor PGF2α PGF2a PGF2.alpha. PGs analogs tetranors FPs receptors luteal IOP glaucoma 2.405237569060
10007931 17-phenyl trinor 8-iso Prostaglandin E2 - ≥95% 2006-07-25 5.631850828729 17-phenyl-trinor-8-iso-prostaglandin-e2 agonists EP1 EP3 prostaglandins receptors 17-phenyl-trinor-PGE2 5.631850828729
14810 17-phenyl trinor Prostaglandin E2 38315-43-4 >98% 59.319171270718 17-phenyl-trinor-prostaglandin-e2 17-phenyl trinor PGE2 agonists EP1 EP3 prostaglandins receptors 17-phenyl-trinor-PGE2 59.319171270718
16810 17-phenyl trinor Prostaglandin F2α Exclusive 38344-08-0 >98% ✓ 60.571522940187 17-phenyl-trinor-prostaglandin-f2 17-phenyl trinor PGF2α; Bimatoprost (free acid) analogs agonists FP receptors 17-phenyl-trinor-PGF2.alpha. 17-phenyl-trinor-PGF2alpha prostaglandins intraocular pressure iop 60.571522940187
16820 17-phenyl trinor Prostaglandin F2α ethyl amide 155206-00-1 >97% 35.135654410364 17-phenyl-trinor-prostaglandin-f2-ethyl-amide 17-phenyl trinor PGF2α ethyl amide; Bimatoprost; 15(S)-Bimatoprost lumigan prostaglandins N-ethylamides intraocular hypotensive agonists IOP glaucoma 17-phenyl-trinor-pgf2alpha-ethylamide 17-phenyl-trinor-pgf2a-ethylamide 17-phenyl-trinor-pgf2.alpha.-ethylamide FP receptors ophthalmology 35.135654410364
14910 19(R)-hydroxy Prostaglandin E2 64625-54-3 >98% 65.321583793738 19-r-hydroxy-prostaglandin-e2 19(R)-hydroxy PGE2; 19(R)-OH PGE2 19(R)-hydroxy-PGE2 19(R)-OH-PGE2 19R-hydroxy-PGE2 19R-OH-PGE2 metabolites semen agonists EP2 prostaglandins receptors hydroxylated PGs 65.321583793738
20190 20-hydroxy Leukotriene B4 79516-82-8 >97% 64.968305709023 20-hydroxy-leukotriene-b4 20-hydroxy LTB4 leukotrienes metabolites 20-hydroxy-LTB4 20-OH-LTB4 hydroxylated 64.968305709023
20195 20-trifluoro Leukotriene B4 115178-97-7 >97% 175.757513812155 20-trifluoro-leukotriene-b4 20-trifluoro LTB4 20-CF3-LTB4 leukotrienes 20-trifluoro-LTB4 metabolites 175.757513812155
62160 2-Arachidonoyl Glycerol 53847-30-6 >95% (as a 9:1 mixture of the 2-AG and 1-AG) 43.426339384372 2-arachidonoyl-glycerol 2-AG endocannabinoids anandamides 2AG fatty acids CB1 neuroscience neurochemistry endocrinology cannabinoids cbs synthetic 43.426339384372
62165 2-Arachidonyl Glycerol ether 222723-55-9 >98% 32.466556169429 2-arachidonyl-glycerol-ether Noladin; 2-AG ether endocannabinoids 2AG anandamides CB1 receptor selective selectivity agonists stable 2-AG-ether analogs fatty acids neurochemistry neuroscience lipids cannabinoids cbs synthetic 32.466556169429
9000787 2-chloro-3-Deazaadenosine 40656-71-1 ≥98% 2011-06-29 1.173011049723 2-chloro-3-deazaadenosine 2-CADO; NSC 158900; 6-Amino-2-chloropurine riboside adenosine receptors analogs agonists seizures neuroscience NSC158900 NSC-158900 neurotransmission A1 A2A A2B A3 G protein-coupled 2-chloroadenosine 2CA 2-CA 2 CA CADO 1.173011049723
90055 (±)-2-Methyl Arachidonoyl-2'-Fluoroethylamide 166100-39-6 >95% 20.331703499079 -2-methyl-arachidonoyl-2-fluoroethylamide O-689; 2-Methyl-2'-fluoro Anandamide; 2-methyl-2'-fluoro AEA anandamides ethanolamides AEA cannabinoids receptors CB1 binding affinity faah fatty acid hydrolases .DELTA.9-THC .DELTA.9THC DELTA9-THC DELTA9THC D9-THC D9THC tetrahydrocannabidiol selective analogs neurochemistry neuroscience fluoromethanandamide 20.331703499079
10005707 (2S)-OMPT - ≥98% 2005-10-19 33.258149171270 -2s-ompt GPR lysophosphatidic acids lipids mediators receptors LPA1/Edg-2 LPA2/Edg-4 LPA3/Edg-7 LPA4/GPR23 agonists calcium mobilization Sf9 cells (2R)-OMPT release assays LPA3-transfected rat hepatoma Rh7777 33.258149171270
10437 3',4'-Methylenedioxy-α-pyrrolidinobutiophenone (hydrochloride) 24622-60-4 ≥97% 2011-08-23 53.196759052719 3-4-methylenedioxy-pyrrolidinobutiophenone-hydrochloride MDPBP designer drugs forensics sciences stimulants PPP MDPV cathinones narcotics pyrrolidinoprophenone methylenedioxpyrovalerone 784985-33-7 53.196759052719
10439 3',4'-Methylenedioxy-α-pyrrolidinopropiophenone (hydrochloride) Exclusive 24698-57-5 ≥97% ✓ 2011-08-24 40.567326816830 3-4-methylenedioxy-pyrrolidinopropiophenone-hydrochloride MDPPP designer drugs forensics sciences narcotics cathinones stimulants PPP MDPV Wistar rats methylenedioxypyrovalerone α-pyrrolidinopropiophenone 783241-66-7 40.567326816830
9000895 4-methoxy DMT Exclusive 3965-97-7 ≥98% ✓ 2011-11-21 40.646844689994 4-methoxy-dmt 4-MeO DMT; 4-methoxy-N,N-Dimethyltryptamine hallucinogen DMT dimethyltryptamine 5-HT receptors agonists 5-hydroxytryptamine behavior neuroscience forensics 4-OMe DMT 4 OMe DMT 4OMe DMT tryptamine 40.646844689994
10449 4'-Methoxy-α-pyrrolidinopropiophenone (tosylate) Exclusive - ≥98% ✓ 2011-08-29 34.562034153691 4-methoxy-pyrrolidinopropiophenone-tosylate MOPPP analogs MDPV forensics sciences 478243-09-3 cathinones designer drugs 34.562034153691
10448 4'-Methyl-α-pyrrolidinohexanophenone (hydrochloride) - ≥98% 2011-10-21 24.901178637201 4-methyl-pyrrolidinohexanophenone-hydrochloride MPHP 34138-58-4 designer drugs forensics pyrovalerone bath salts MPPP PPP α-PPP α PPP psychostimulant toxic liver damage rabdomyloysis 24.901178637201
10446 4'-Methyl-α-pyrrolidinopropiophenone (hydrochloride) Exclusive 1313393-58-6 ≥97% ✓ 2011-08-25 51.937997237568 4-methyl-pyrrolidinopropiophenone-hydrochloride 4-MeMPPP designer drugs forensics pyrrolidinyl narcotics cathinones PPP metabolism stimulants MDMA receptors agonists analogs 28117-80-8 MPPP 51.937997237568
11094 4-Quinolone-3-Carboxamide Furan CB2 Agonist New 1314230-75-5 ≥98% 2012-02-28 32.235202229476 4-quinolone-3-carboxamide-furan-cb2-agonist 4Q3C CB2 Agonist cannabinoids CBs agonists receptors CB1 CB2 AM630 pain neuroscience osteoporosis inflammation anti-inflammatory bones research peripheral AM630 AM 630 AM-630 32.235202229476
18211 5-cis Carbaprostacyclin 69609-77-4 >99% 2.117771639042 5-cis-carbaprostacyclin (5Z)-6a-Carbaprostaglandin I2 PGI2 analogs prostaglandins 5(z)-carbaprostacyclin 5z-carbaprostacyclin 5-cis-carbaprostacyclin 2.117771639042
10008585 5-cis Iloprost - ≥97% 2006-07-17 51.315414364641 5-cis-iloprost 5-cis Ciloprost agonists IP receptors vasodilator hypostensive antiduretic hypertension analogs PGI2 prostaglandins carbaprostacyclin selective selectivity C-5 cis-isomers 15-keto-iloprost 51.315414364641
34250 5-OxoETE 106154-18-1 ≥95% 17.745280189423 5-oxoete 5-KETE 5-HETEs oxo-acids 5-LOs metabolites chemotactic fatty 5-lipoxygenases 5-oxo-etes polyunsaturated PUFAs 17.745280189423
100025 5-OxoETE Receptor Polyclonal Antibody - 2004-12-14 255.799907918968 5-oxoete-receptor-polyclonal-antibody TG1019; R527 WB western blots blotting ICC immunocytochemistry 5-HETEs oxo-acids chemotactic chemotaxis 5-lipoxygenases 5-oxo-etes leukocytes PUFAs stimulators eosinophils neutrophils GPCR G-proteins coupled Gi/o cAMP cyclic inflammatory kidney liver receptors antibodies antisera antiserum 5oxoete immunoblotting 255.799907918968
11031 6-ECDCA New 459789-99-2 ≥95% 2012-03-14 21.123287671233 6-ecdca INT 747; Obeticholic Acid cholesterol cholestasis diabetes fibrosis receptors agonists calcification adipogenesis obesity FXR chenodeoxycholic acids CDCA ligands 6-ethyl CDCA 6 ethyl CDCA 6 CDCA livers fibrosis genes kidneys diseases atherosclerosis INT-747 21.123287671233
13655 Adapalene 106685-40-9 ≥98% 2010-09-10 3.225635359116 adapalene Differin; CD 271 agonists retinoic acids differentiation anti-inflammatory inflammation antiinflammatory anti inflammatory RARs RAR-β RARβ β RAR-b RARb RARbeta RAR-beta RAR-.beta. RAR.beta. RAR-γ RARγ RARg RAR-g RARgamma RAR-gamma RAR.gamma. RAR-.gamma. CD-271 CD271 Naphthalenes 3.225635359116
13626 AFP 07 (free acid) Exclusive 788799-13-3 ≥98% ✓ 2011-08-31 13.792541436464 afp-07-free-acid prostaglandins I2 PGI2 PGs prostacyclins IP receptors agonists EP1 EP2 EP3 EP4 AH 23848 AH-23848 prostanoids platelets vasodialation aggregation pulmonary vascular AH23848 AFP07 AFP-07 13.792541436464
10011546 AL 34662 210580-75-9 ≥98% 2008-11-12 45.421248618784 al-34662 AL 34497 serotonins 5-HTs 5HT 5-hydroxy trptamine IOPs intraocular pressure glaucoma ophthalmology lower 5-hydroxytrptamine 45.421248618784
13620 AL 6598 Exclusive 170291-06-2 97% ✓ 2010-09-16 98.823082872928 al-6598 intraocular pressures IOPs glaucoma PGD2 agonists DP receptors eyes hypertension F2 alpha Prostaglandin Prostaglandin F2 alpha F2alpha Prostaglandin Prostaglandin F2alpha 9alpha,11beta-PGF2 9alpha,11beta PGF2 Prostaglandin F2 Enzaprost F alpha, PGF2 PGF2 alpha PGF2alpha Dinoprost Estrofan PGF2 98.823082872928
13452 AM3102 Exclusive 213182-22-0 ≥98% ✓ 2009-08-11 40.003752932898 am3102 KDS-5104 OEA PPARs PPARα KDS5104 antiobesity anti-obesity CB1 CB2 endocannabinoids obesity cannabinoids inhibitors agonists receptors cbs synthetic 40.003752932898
13523 Apelin-13 217082-58-1 ≥95% 2010-06-29 36.988508287293 apelin-13 ligands APJ receptors central nervous system cardiovascular functions fluid homeostasis neurosciences hypertension diabetes metabolic syndrome insulin HIV aids Peptide Factors Paracrine Paracrine Protein Factors Paracrine Peptide Factors Growth Factors 36.988508287293
13524 Apelin-36 252642-12-9 ≥95% 2011-04-04 34.961381215469 apelin-36 agonists receptors APJ cardiovascular functions fluids homeostasis hypertension insulin sensitivity apelin-17 apelins 17 13 36 apelin-13 HIV infections peptides mature G protein-coupled GPCR c-protein coupled 34.961381215469
91054 Arachidonoyl 2'-Chloroethylamide 220556-69-4 >96% 26.423195211786 arachidonoyl-2-chloroethylamide 2'-chloro-AEA; ACEA agonists selective CB1 receptors AEA arachidonoyl ethanolamides cannabinoids selectivity hypothermia FAAH fatty acid amide hydrolases neurochemistry neuroscience thc tetrahydrocannabinoids ethanolamines 26.423195211786
90054 Arachidonoyl-2'-Fluoroethylamide 166100-37-4 >98% 4.681927886013 arachidonoyl-2-fluoroethylamide 2'-fluoro Anandamide; 2'-fluoro AEA anandamides cannabinoids neurotransmitters ligands AEA lipids CB1 CB2 receptors neurochemistry neuroscience 4.681927886013
90050 Arachidonoyl Ethanolamide 94421-68-8 ≥98% 44.704675456451 arachidonoyl-ethanolamide Anandamide; AEA cannabinoids neurotransmitter ligands lipids CB1 CB2 receptors AEA fatty acids neuroscience neurochemistry ethanolamines ethanolamides endocrinology 44.704675456451
62170 Arachidonoyl Serinol 183718-70-9 >98% 37.453093922652 arachidonoyl-serinol endocannabinoids anandamides 2AG CB1 receptors neurochemistry neuroscience cannabinoids cbs synthetic 37.453093922652
90052 Arvanil 128007-31-8 >98% 13.559889502762 arvanil N-Vanillylarachidonamide capsaicin capsicum vanilloids receptors agonists cannabinoids analgesia anandamides analgesic vanillylamines amides neurochemistry neuroscience 13.559889502762
10626 AS-1269574 Exclusive 330981-72-1 ≥98% ✓ 2011-01-17 7.888581952118 as-1269574 diabetes glucose insulin receptors pancrease b-cells b cells .beta.-cells beta-cells β-cells β GPR119 GPR-119 GPR 119 lysophosphatidylcholine LPC oleoylethanol amides OEA agonist Ethanolamines Aminoethanols 7.888581952118
18230 Beraprost (sodium salt) 88475-69-8 >98% 76.308876611418 beraprost-sodium-salt TRK 100; Procyclin; ML 1129 prostaglandins inhibitors inhibits PGI2 prostacyclin platelets aggregation pulmonary atherosclerosis hypertension analogs salts ML-1129 ML1129 TRK-100 TRK100 Na+ 76.308876611418
11571 Bexarotene New 153559-49-0 ≥98% 2012-04-06 47.635666052793 bexarotene LGD 1069; SR 11247; Ro 26-4455; LG 100069; Targretin retinoid X receptors ligands agonist RXR genes expression cancers alzheimers diseases apoptosis angiogenesis metastasis cells proliferations β-amyloid amyloids βamyloid LG 100069 1069 69 LG-100069 LG-1069 LG-69 LGD 1069 LGD-1069 LGD1069 LG100069 LG1069 LG69 RO 26-4455 RO26-4455 RO-26-4455 RO 264455 RO-264455 RO264455 SR 11247 SR-11247 SR11247 targret targretin targretyn targrexin 47.635666052793
13740 Butaprost Exclusive 69685-22-9 >98% ✓ 93.793453038673 butaprost TR 4979; 15-deoxy-16S-hydroxy-17-cyclobutyl PGE1 methyl ester PGE2 prostaglandins R-butaprost PGE1 methyl esters EP2 receptors (R)-butaprost (R)butaprost 93.793453038673
10393 Butylone (hydrochloride) 17762-90-2 ≥97% 2011-08-17 66.209861513909 butylone-hydrochloride β-keto MBDB designer drugs forensics receptors agonists bath salts MBDB MDMA cathinone methylbenzodioxolylbutanamine methylenedioxymethamphetamine 802575-11-7 butylone 66.209861513909
12050 BW 245C 72814-32-5 >98% 82.170593922651 bw-245c PGD2 hydantoins agonists BW245C prostaglandins BW-245C 82.170593922651
70090 BW 723C86 160521-72-2 >98% 22.216353591159 bw-723c86 bw-723c86 bw723-c86 5-ht2b agonist anxiolytic serotonin 5-hydroxy-tryptamine 5-OH-tryptamine bw723c86 receptors selective endocrinology neurochemistry neuroscience 22.216353591159
92350 Capsaicin 404-86-4 ≥95% 2004-04-01 11.165374901341 capsaicin Capsicum peppers VR1 vanilloid receptors pain heat hot extracts nociceptive burning neurochemistry neuroscience lipid-soluble extracts calcium ca+ ion channels pathways desensitization non-myelinatedpolymomdal c-type nerve fibers 11.165374901341
18210 Carbaprostacyclin 69552-46-1 >99% 82.885651144435 carbaprostacyclin Carbacyclin; cPGI analogs vasodilation PPARs peroxisome proliferator-activated receptors PGI2 prostaglandins atherosclerosis cPGI Carbacyclin 82.885651144435
19010 Carbocyclic Thromboxane A2 74034-56-3 >98% 7.788453038674 carbocyclic-thromboxane-a2 CTA2; Carbocyclic TXA2 thromboxanes analogs TXA2 vasoconstriction CTA2 atherosclerosis 7.788453038674
13747 CAY10408 212310-16-2 >98% 30.079502762430 cay10408 PGE2 prostaglandins R-butaprost C-16 epimer EP2 receptors (R)-butaprost (R)butaprost PGE2 30.079502762430
10008669 CAY10508 878533-35-8 ≥98% 2006-08-04 35.284060773480 cay10508 1,3-bis(4-bromophenyl)-5-phenyl-Imidazolidine-2,4-dione central peripheral cannabinoids receptors inverse agonists antagonists therapeutic therapy obesity drug dependence CB1 CB2 CP-55,940 cannabinoids cbs synthetic 35.284060773480
10009167 CAY10509 1245699-47-1 ≥98% 2006-10-25 87.593895027624 cay10509 FP PGF2.alpha. glaucoma compound A receptors agonists intraocular pressure glaucoma IOP ophthalmology 87.593895027624
10009168 CAY10510 291303-34-9 ≥98% 2006-10-25 87.448038674032 cay10510 FP PGF2.alpha. glaucoma Compound B receptors agonists intraocular pressure glaucoma IOP ophthalmology 87.448038674032
16835 CAY10580 Exclusive 64054-40-6 ≥96% ✓ 2009-03-16 77.803241252302 cay10580 PGEs PGE2 receptors inhibitors inhibits inhibition antagonist blockers EP4 cAMPs bones fromation resorption cancers atherosclerosis 77.803241252302
10012424 CAY10583 Exclusive 862891-27-8 ≥98% ✓ 2009-07-21 61.190257826887 cay10583 LTB4 leukotrienes B4 LTBs BLT1 BLT2 BLTs agonist aggregation inflammation increases calcium intracellular stores induces ERK phosphorylation 61.190257826887
13143 CAY10587 Exclusive 1082058-99-8 ≥98% ✓ 2009-07-02 14.766325966851 cay10587 free fatty acid receptor1 FFA1 GPR40 pancreatic b-cells glucose insulin diabetes obesity metabolic syndrome receptors 14.766325966851
13281 CAY10598 Exclusive 346673-06-1 ≥98% ✓ 2010-05-07 55.690121546961 cay10598 Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection 55.690121546961
13282 CAY10599 Exclusive 1143573-33-4 ≥98% ✓ 2009-07-21 39.161461019030 cay10599 thiazolidinedione PPARs PPARγ agonist rosiglitazones BRL 49653 BRL49653 BRL-49653 diabetes TZDs 39.161461019030
10010398 CB-13 432047-72-8 ≥98% 2009-06-30 38.500490737732 cb-13 CRA-13 cannabinoids CB1 CB2 central peripheral receptors agonists pains hyperalgesia blocks blocking CB13 CB 13 CRA13 CRA 13 38.500490737732
16831 Cicaprost Exclusive 94079-80-8 ≥98% ✓ 2010-09-16 48.114404821697 cicaprost ZK 96480 Prostaglandin I2 PGI2 prostacyclins vasodilators cardiovascular diseases inflammation mitogenesis cancers orally active inflammatory Epoprostenol Sodium(5Z,9alpha,11alpha,13E,15S)-Isomer Epoprostenol Sodium Prostaglandin I(2) Prostaglandin I2 Prostacyclin Epoprostenol Epoprostanol Flolan PGI2 PGX 48.114404821697
18216 Ciprostene (calcium salt) 81703-55-1 ≥98% 38.628701657458 ciprostene-calcium-salt U-61431F; Ciprostene calcium PGI2 analogs vasodilation 9.beta.-methyl 9beta-methyl carbaprostacyclin prostaglandins salts cat U61431F atherosclerosis 38.628701657458
16765 (+)-Cloprostenol 54276-21-0 ≥97% 61.374996053669 -cloprostenol (+)-16-m-chlorophenoxy tetranor Prostaglandin F2α; D-Cloprostenol; (+)-16-m-chlorophenoxy tetranor PGF2α PGF2.alpha. PGF2alpha luteolysis analogs prostaglandins agonists FP receptors enantiomer pharma:6 61.374996053669
16766 (+)-Cloprostenol (sodium salt) 62561-03-9 ≥98% 60.455106550907 -cloprostenol-sodium-salt (+)-16-m-chlorophenoxy tetranor Prostaglandin F2α; (+)-16-m-chlorophenoxy tetranor PGF2α; D-Cloprostenol FP receptors agonists luteolysis analogs PGF2.alpha. PGF2alpha prostaglandins salts Na+ D-Cloprostenol pharma:4 60.455106550907
16764 Cloprostenol (sodium salt) 55028-72-3 ≥98% 65.293245856353 cloprostenol-sodium-salt DL-Cloprostenol; (±)-16-m-chlorophenoxy tetranor Prostaglandin F2α; (±)-16-m-chlorophenoxy tetranor PGF2α PGF2.alpha. PGF2alpha luteolysis analogs prostaglandins agonists FP receptors (+/-)-cloprostenol ±cloprostenol DL-Cloprostenol pharma:3 65.293245856353
11015 Dexamethasone 50-02-2 ≥98% 2011-10-25 23.483646408839 dexamethasone MK 125; NSC 34521 steroids hormones glucocorticoid agonist receptors inflammation genes expression anti-inflammatory antiinflammatory anti inflammatory 8054-59-9 137098-19-2 906362-70-7 906422-84-2 1050677-47-8 adexone aeroseb-Dex aphtasolon aphthasolone azium calonat corsone cortisumman decacort decaderm decadron A decalix decasone dekacort dekort delipos deltafluorene dergramin deronil desadrene desameton deseronil dexa-cortidelt dexa-mamallet dexa-scheroson dexa-sine dexacort dexacortal dexacortin dexadeltone dexafarma dexalona dexaltin dexameth dexamethasone alcohol dexamonozon dexapolcort dexapos dexaprol dexason dexasone dexinoral dexmethsone dexone dexonium dextelan dinomon diodex etacortilen fluormone fluorocort gammacorten gentalipos HL-dex hexadecadrol hexadrol isopto-dex lokalison F loverine luxazone MK-125 MK125 maxidex millicorten NSC-34521 NSC34521 oradexon pet-derm III posurdex prednisolon F prednisolone superprednol surodex visumetazone 23.483646408839
92355 Dihydrocapsaicin 19408-84-5 ≥98% 7.067521704814 dihydrocapsaicin capsicum peppers VR1 receptors non-myelinated polymodal C-type nociceptive nerve fibers calcium ion channels pain pathways CA2+ vanilloid heat-activated neurochemistry hot extracts burning neuroscience lipid-souble desensitization patyways 7.067521704814
13184 (±)-Equol 94105-90-5 ≥98% 2009-09-03 6.176095764272 -equol phytoestrogens estrogens daidzen genistein receptors cancers nonsteroidal ERα ERβ ERalpha ER.alpha. ERbeta ER.beta. breast cells proliferation 7,4'-homoisoflavone NV 07α 07alpha 66036-38-2 6.176095764272
16768 Fluprostenol Exclusive 54276-17-4 ≥95% ✓ 77.438950276243 fluprostenol 16-m-trifluoromethylphenoxy tetranor PGF2α 16767 PGF2alpha PGF2.alpha. analogs FP agonists luteolysis prostaglandins receptors (+)-Fluprostenol 77.438950276243
16769 Fluprostenol isopropyl ester 157283-68-6 ≥98% 41.083650401512 fluprostenol-isopropyl-ester Flu-Ipr; Travoprost; 16-m-trifluoromethylphenoxy tetranor PGF2α isopropyl ester esters prodrug FP receptors agonists intraocular hypotensive IOP glaucoma analogs prostaglandins travatan ophthalmology 41.083650401512
10004236 Fluprostenol serinol amide - ≥98% 2004-09-23 7.056596685083 fluprostenol-serinol-amide Flu-SA PGF2.alpha. PGF2alpha analogs agonists prostaglandins receptors amides cannabinoids CB1 CBs synthetic 7.056596685083
10006292 FTY720 162359-56-0 ≥98% 2005-02-09 227.489226519337 fty720 immune modulators sphingosine-1-phosphate receptors ISP1 S1P1 S1P5 S1P3 S1P4 ISP-1 myriocin kinases Abcc1 derivatives Iscaria sinclarii transplants transporter activity FTY 720 227.489226519337
10851 Guanabenz (hydrochloride) - ≥98% 2011-09-30 0E-12 guanabenz-hydrochloride Wytensin adrenergic receptors hypertension imidazoline adipose tissues neurosciences cardiovascular diseases agonists 5051-62-7 α2 alpha2 I2 hydrochloride HCl 0E-12
10010372 GW 842166X 666260-75-9 ≥98% 2008-05-23 34.145428176795 gw-842166x inflammatory pain arthritis neuropathic hyperalgesia CB2 cannabinoids agonists anandamide receptors neurochemistry cannabinoids cbs synthetic 34.145428176795
10008907 GW 9508 885101-89-3 ≥98% 2007-05-14 22.284447513812 gw-9508 agonists GPR40 GPR120 G protein receptors fatty acid glucose insulin MIN6 coupled endocrinology GW9508 22.284447513812
19600 I-BOP Exclusive 128719-90-4 ≥95% ✓ 78.543204419889 i-bop IBOP TXA2 analogs vasoconstriction agonists TP receptors 78.543204419889
10137 Icilin 36945-98-9 ≥98% 2004-04-27 13.087421731123 icilin AG 3-5 cooling agent cold receptors CMR1 neurons transient receptors potential VR1 vanilloid receptos TRPM8 neurochemistry neuroscience 13.087421731123
18215 Iloprost 78919-13-8 ≥97% 174.348213627993 iloprost Ciloprost agonists IP receptors vasodilator hypostensive atherosclerosis antiduretic hypertension analogs PGI2 prostaglandins prostacyclin selective selectivity pharma:21 174.348213627993
70275 IMMA - ≥98% 12.406973603437 imma Indomethacin Morpholinylamide; BML-190 cannabinoids receptors CB2 neuroscience neurochemistry endocrinology 12.406973603437
10004974 Ionomycin 56092-81-0 ≥98% 2011-09-30 18.423959484346 ionomycin ionophores calcium transport streptomyces conglobatus intracellular cytokines membranes stores biological SQ23377 SQ-23377 SQ 23377 D10.251.355.391 18.423959484346
13633 JWH 019 209414-08-4 ≥98% 2010-01-14 51.392604445863 jwh-019 cannabinoids CB1 CB2 receptors THC JWH-019 JWH019 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinol cannabinmimetic indoles cannabinoids cbs synthetic JWH019 JWH-019 JWH19 JWH 19 JWH-19 51.392604445863
10009280 L-759,633 174627-50-0 >98% 2007-09-13 33.291215469613 l-759-633 L759633 cannabinoids receptors agonists CB1 CB2 endocrinology neurochemistry cannabinoids cbs synthetic 33.291215469613
10007712 L-902,688 Exclusive 634193-54-7 ≥98% ✓ 2010-05-07 42.970236779794 l-902-688 PGE2 bones growth EP4 agonists hyperalgesia vasodialation 42.970236779794
16812 Latanoprost 130209-82-4 >98% 314.374212154695 latanoprost CAY530500; 17-phenyl-13,14-dihydro trinor Prostaglandin F2α isopropyl ester; 17-phenyl-13,14-dihydro trinor PGF2α isopropyl ester eyes ophthalmology ophthalmological intraocular glaucoma esters FP receptors agonists IOP pressure prostaglandins 17-phenyl-13,14-dihydro-trinor-PGF2.alpha. 17-phenyl-13,14-dihydro-trinor-PGF2alpha 314.374212154695
16811 Latanoprost (free acid) 41639-83-2 ≥98% 97.537305972112 latanoprost-free-acid PhXA-85; Lat-FA; 17-phenyl-13,14-dihydro trinor Prostaglandin F2α eyes glaucoma prostaglandins agonists FP receptors phxa85 ophthalmology ophthalmological intraocular acids 17-phenyl-13,14-dihydro-trinor-PGF2.alpha. PhXA85 17-phenyl-13,14-dihydro-trinor-PGF2alpha IOP 97.537305972112
20110 Leukotriene B4 71160-24-2 ≥97% 180.943799155021 leukotriene-b4 LTB4 leukotrienes LTB4 inflammation chemotaxis atherosclerosis 180.943799155021
20114 Leukotriene B4-3-aminopropylamide 89596-43-0 ≥95% 2009-03-05 429.324088397790 leukotriene-b4-3-aminopropylamide LTB4-3-aminopropylamide LTB LTB4 BLTs BLT1 BLT2 inflammation immunology 429.324088397790
20210 Leukotriene C4 72025-60-6 ≥97% 146.582855481245 leukotriene-c4 LTC4 cysteinyl-leukotrienes LTC4 asthma SRS-A slow-reacting substance anaphylaxis allergy peptido-leukotrienes cysteinyl-LTs peptido-LTs cys-LTs 146.582855481245
20310 Leukotriene D4 73836-78-9 >97% 162.167262124002 leukotriene-d4 LTD4 cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes LTD4 asthma SRS-A bronchoconstriction peptido-leukotrienes slow-reacting substance anaphylaxis allergy metabolites 162.167262124002
20410 Leukotriene E4 75715-89-8 >97% 91.881151721207 leukotriene-e4 LTE4 peptido-leukotrienes LTE4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes 91.881151721207
10979 MDMA methylene homolog (hydrochloride) Exclusive - ≥98% ✓ 2011-06-22 31.106511302061 mdma-methylene-homolog-hydrochloride 3,4-Methylenedioxymethamphetamine methyl homolog forensic sciences cannabinoids CBs pyrovalerones pentylones designer drugs forensics neuroscience psychoactive ecstasy HCl 31.106511302061
10749 Methylhexanamine (hydrochloride) 13803-74-2 ≥98% 2011-10-07 24.752394106814 methylhexanamine-hydrochloride Forthane; NSC 1106; DMAA; Geranamine; Floradrene; Dimethylamylamine stimulants designer drugs forensics sciences amphetamines amines nasal decongestant cerebral hemorrhage forthan methylhexaneamine 105-41-9 HCl allphatic floradrene 24.752394106814
13820 Misoprostol 59122-46-2 >98% 25.366596685083 misoprostol SC-29333; Cytotec cytoprotection PGE1 analogs agonists EP2 EP3 EP4 receptors SC29333 RU-486 RU486 25.366596685083
11151 Mitragynine New 4098-40-2 ≥95% 2011-12-01 38.039228629241 mitragynine Kratom; 9-methoxy Corynantheidine alkaloids forensics Mitragyna pain neuroscience opioids receptors agonists incense indoles plants noradreneric serotonergic metabolites 11047-39-5 36455-45-5 1383-32-0 6202-22-8 38.039228629241
10010412 MRE-269 Exclusive 475085-57-5 ≥98% ✓ 2008-11-06 63.403342541436 mre-269 MRE269 prostaglandins PGI2 IP receptors inflammation NS-304 NS304 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs prodrugs 63.403342541436
13667 Muscimol 2763-96-4 ≥98% 2010-05-28 14.333144396698 muscimol Pantherine; Agarin γ-aminobutyric acid GABA neurotransmitters GABAA GABAC GABAB agonists benzodiazepines memory neurochemistry neuroscience GABA-A Receptor alpha Subunit GABA Benzodiazepine Receptors GABA A Receptor gamma Subunit GABA A Receptor delta Subunit GABA A Receptor alpha Subunit GABA Benzodiazepine Receptor GABA A Receptor beta Subunit Benzodiazepine-GABA Receptor Benzodiazepine GABA Receptor GABA-A Receptor rho Subunit GABA A Receptor rho Subunit Benzodiazepine Receptors Benzodiazepine Receptor Receptors Muscimol Receptors, Diazepam Muscimol Receptor Diazepam Receptor GABA A Receptors GABA-A Receptor GABA A Receptor 14.333144396698
10517 Naphyrone (hydrochloride) 850352-11-3 ≥97% 2011-08-29 105.016779230112 naphyrone-hydrochloride O-2482; NRG-1; Naphpyrovalerone; β-Naphyrone analogs MDPV forensics sciences designer drugs 850352-53-3 pyrovalerones cathinones dopamine serotonins norepinephrines bath salts 105.016779230112
13390 N-methyl Leukotriene C4 131391-65-6 >97% 2008-10-15 85.482108655616 n-methyl-leukotriene-c4 N-methyl LTC4 allergy allergies asthma anaphylaxis SRS-A cysteinyl leukotrienes LTs mimetics 85.482108655616
10115 N-Oleoyl Dopamine 105955-11-1 ≥98% 5.504001578531 n-oleoyl-dopamine ODA VR1 agonists CB1 receptors analogs vanilloids cannabinoids analgesic amides N-oleoyldopamine inhibits inhibitors inhibition 5-lipoxygenases 5-LOs binding selective FAAH hydrolases fatty acid neurochemistry neuroscience cbs synthetic 5.504001578531
10010411 NS-304 475086-01-2 ≥98% 2008-04-09 39.075902394106 ns-304 ACT-293987; Selexipag prostaglandins PGI2 IP receptors inflammation MRE-269 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs 39.075902394106
10009195 O-2545 (hydrochloride) - ≥98% 2007-07-12 5.521546961326 o-2545-hydrochloride cannabinoids water soluble agonists receptors CB1 CB2 lipophilic surfactants 874745-42-3 murine models intravenously IV 02545 intracerebroventricularly endocrinology neurochemistry cannabinoids cbs synthetic 5.521546961326
11614 Olmesartan Medoxomil New 144689-63-4 ≥98% 2012-05-18 99.077747084100 olmesartan-medoxomil Olmetec; Benicar; CS 866 prodrugs angiotensin II receptors antagonists blood pressure hypertension cardiovascular disease atherosclerosis CS866 CS 866 in vivo RNH-6270 RNH 6270 RNH6270 AT1 AT2 blood pressure cardiovascular parameters CS-866 99.077747084100
90262 Olvanil 58493-49-5 ≥98% 6.452605893185 olvanil NE 19550; N-Vanillyloleamide capsaicin capsicum vanilloids receptors agonists cannabinoids analgesia anandamides analgesic vanillylamines amides analogs neurochemistry neuroscience 6.452605893185
11347 Penitrem A New 12627-35-9 ≥98% 2012-03-05 16.753229974160 penitrem-a Tremortin A; NSC 354845 12679-82-2 inhibitors inhibits inhibition channels blockers potassium BKCa cells signaling smooth muscles vascular cardiovascular neuronal neuroscience SLO1 Maxi-K fungal fungus toxins 16.753229974160
11011 Pentedrone (hydrochloride) Exclusive 879669-95-1 ≥98% ✓ 2011-08-23 85.704326968520 pentedrone-hydrochloride α-methylamino-Valerophenone analogs MDPV forensics sciences 879722-57-3 cathinones alkaloids psychotropics bath salts neurological HCl monoamine alkaloids methcathinone pentadrone 85.704326968520
9000849 Phenazepam 51753-57-2 ≥98% 2011-02-14 109.638796807857 phenazepam Fenazepam; BD 98 benzodiazepine agonists GABAA receptors anxiolytic sedative anticonvulsive anti-convulsive anti convulsive hypnotic tranquilizers 109.638796807857
12010 Prostaglandin D2 41598-07-6 ≥99% 162.543959850903 prostaglandin-d2 PGD2 Vasodilation prostaglandins brain sleep platelets aggregation. H-PGDS synthases mast cells hematopoietic allergic allergy asthmatic anaphylaxis hypotension inhibits inhibitors inhibition beta-trace .beta.-trace b-trace neurochemistry 162.543959850903
10192 Prostaglandin D2 serinol amide - >98% 2004-05-13 38.065237569061 prostaglandin-d2-serinol-amide PGD2-SA PGD2 vasodilation prostaglandins brain sleep platelets aggregation anandamides serinols amides cannabinoids AEA 38.065237569061
14010 Prostaglandin E2 363-24-6 ≥99% 254.887908687252 prostaglandin-e2 PGE2; Dinoprostone PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins pharma:2 254.887908687252
10140 Prostaglandin E2-1-glyceryl ester 37497-47-5 >98% (as a 85:15 mixture of the 1- and 2-glyceryl esters) 50.722817679558 prostaglandin-e2-1-glyceryl-ester PGE2-1-glyceryl ester Prostaglandins PGE2-1-GE esters 2-AG 2-arachidonyl-glycerol metabolites COX-2 PGHS-2 cycloxygenases synthases PGE2-2-GE COX2 PGHS2 cannabinoids cbs synthetic 50.722817679558
14012 Prostaglandin E2 Ethanolamide Exclusive 194935-38-1 >98% ✓ 43.989917127072 prostaglandin-e2-ethanolamide PGE2-EA; Dinoprostone Ethanolamide; Prostamide E2 anandamides ethanolamides cannabinoids PGE2 prostaglandins AEA analogs neurochemistry neuroscience ethanolamines prostamides 43.989917127072
10193 Prostaglandin E2 serinol amide Exclusive - ≥98% ✓ 2004-03-03 36.179234411997 prostaglandin-e2-serinol-amide PGE2-SA PGE2SA cannabinoids agonists CB1 receptors analogs 2-glyceryl neurochemistry neuroscience 36.179234411997
16010 Prostaglandin F2α 551-11-1 ≥99% 62.148576378792 prostaglandin-f2 PGF2α; Dinoprost PGF2alpha PGF2.alpha. Lutalyse vasoconstriction bronchoconstriction prostaglandins endocrinology prostaglandin f2alpha f2 alpha prostaglandin f2 alpha 62.148576378792
10194 Prostaglandin F2α serinol amide - >98% 2004-02-23 14.588425414364 prostaglandin-f2-serinol-amide PGF2α-SA PGF2alphaSA PGF2.alpha.SA PGF2alpha-SA PGF2.alpha.-SA cannabinoids agonists CB1 recptors analogs 2-glyceryl esters amides neuroscience 14.588425414364
18220 Prostaglandin I2 (sodium salt) 61849-14-7 ≥99% 83.555215469612 prostaglandin-i2-sodium-salt Prostacyclin; Epoprostenol; PGI2 PGI2 metabolites prostaglandins salts Na+ COX cyclooxygenases atherosclerosis 83.555215469612
18500 Prostaglandin J2 60203-57-8 >95% 43.939123914759 prostaglandin-j2 PGJ2 PGJ2 PGD2 metabolites PPARs prostaglandins peroxisome proliferator-activated receptors 43.939123914759
10008593 PSN375963 388575-52-8 ≥98% 2006-08-01 13.764375690607 psn375963 GPR119 SNORF25 agonists oleoylethanolamide OEA obesity appetite food intake GPCR G protein-coupled receptors PSN632408 weight gain pancreas gastrointestinal tract brain endocrinology 13.764375690607
10008594 PSN632408 Exclusive 857652-30-3 ≥98% ✓ 2006-08-01 16.772696132596 psn632408 GPR119 SNORF25 agonists oleoylethanolamide OEA obesity appetite food intake GPCR G protein-coupled receptors PSN632408 weight gain pancreas gastrointestinal tract brain endocrinology neurochemistry 16.772696132596
10009634 Purmorphamine 483367-10-8 ≥98% 2007-07-19 126.553162695672 purmorphamine stem cells differentiation osteoblasts osteogenesis osteoporosis bone smoothened hedgehog progenitor cells expression signalling pathways signaling transmembrane agonists receptors 126.553162695672
10798 RCS-4-C4 homolog Exclusive - ≥98% ✓ 2011-04-21 42.903849575109 rcs-4-c4-homolog BTM-4; SR-19; OBT-199; E-4 cannabinoids cannabimimetic metabolites CB1 CB2 receptors agonists spice forensics synthetics smoking urinary urine serum JWH018 JWH 018 JWH-018 JWH18 BTM4 BTM 4 E4 E 4 OBT199 OBT 199 SR19 SR 19 42.903849575109
10010172 (R)-Equol Exclusive 221054-79-1 ≥98% ✓ 2009-08-27 5.189150552485 -r-equol Isoequol; (+)-Equol phytoestrogens estrogens daidzen genistein receptors cancers R-Equol +equol + equol agonist activity R equol (R) equol 5.189150552485
11017 Retinoic Acid 302-79-4 ≥98% 2011-10-25 17.543287906690 retinoic-acid ATRA; Tretinoin; NSC 122758; Vitamin A Acid; all-trans Retinoic Acid; NSC 122578 ligans receptor cancers development reproduction immunity gene expressions 7005-78-9 56573-65-0 187175-63-9 NSC-122758 NSC122758 AGN 100335 AGN100335 AGN-100335 aberel airol aknoten atragen cordes vas dermairol epi-aberel eudyna NSC 122578 NSC-122578 NSC122578 renova retacnyl retin A ro 1-5488 tretin M vesanoid vesnaroid vitamins A1 all trans 17.543287906690
9000484 Rimonabant 168273-06-1 ≥98% 2009-06-17 74.152900552486 rimonabant SR141716 SR 141716A SR141716A CB1 inverse agonists anti-obesity immunomodulation anti-proliferation appetite suppressants receptors weight control medication cannabinoids anti-proliferative immunodulatory cbs sythetic 74.152900552486
10010173 (S)-Equol 531-95-3 ≥98% 2009-08-27 10.549703038674 -s-equol 4',7-Isoflavandiol; 4',7-Dihydroxyisoflavan; (-)-Equol phytoestrogen estrogens daidzen genistein receptors cancers (S) equol S-equol -Equol (-) Equol antagonist 10.549703038674
10006440 SEW2871 256414-75-2 >98% 2005-03-09 81.383655616943 sew2871 FTY720 sphingosines 1-phosphates receptor-1 S1P1 agonists immunosuppression brandycardia G-proteins receptors lymphocytes recirculation blood heart rate GPR FTY 720 sew 2871 81.383655616943
62570 Sphingosine-1-Phosphate 26993-30-6 ≥98% 130.741114497999 sphingosine-1-phosphate S1P; Sphingosine-1-Phosphoric Acid sphingosines phosphates ceramides apoptosis Sphingosine-1-phosphoric acids cells death kinases sphingomyelin growth calcium 130.741114497999
10683 SR 16584 1150153-86-8 ≥95% 2011-11-17 41.539337016574 sr-16584 antagonists receptors nicotinic acetylcholine receptors neuroscience nAChRs ligands ion channels central peripheral nerves nervous system subtypes SR-16584 SR16584 α3β4 α4β2 α7 41.539337016574
14765 Sulprostone 60325-46-4 >98% 184.736961325967 sulprostone 16-phenoxy-PGE2 EP3 agonists selective analogs receptors 184.736961325967
13830 Synthetic Cannabinoid HPLC Mixture I - ≥95% for each compound 2010-05-13 40.045118847375 synthetic-cannabinoid-hplc-mixture-i cannabinoids CBs endocannabinoids cannabidiols CP-47,497 cp 47,497 47,497-c8-homolog CP-47,497-C8 homolog analog CP-55,940 cp47,497 cp55,940 cp 55,940 HU-331 HU331 HU 331 HU308 HU 308 HU-308 JWH-015 jwh015 jwh 015 jwh 018 jwh018JWH-018 JWH-200 jwh200 jwh 200 jwh 250 jwh250 JWH-019 Win-55212-2 Jwh-250 win 55212-2 win55212 2 synthetic spices mixes synthetic 40.045118847375
13850 Synthetic Cannabinoid HPLC Mixture II - ≥95% for each compound 2010-12-21 44.388457144890 synthetic-cannabinoid-hplc-mixture-ii cannabinoids CBs synthetics mixtures receptors agonists synthetic 44.388457144890
11335 Synthetic Cannabinoid HPLC Mixture III New - ≥95% for each compound 2012-03-20 75.250490689850 synthetic-cannabinoid-hplc-mixture-iii cannabinoids CBs synthetics mixtures receptors agonists JWHs AMs RCS 75.250490689850
11336 Synthetic Cannabinoid HPLC Mixture IV New - ≥95% for each compound 2012-05-03 100.564303915699 synthetic-cannabinoid-hplc-mixture-iv cannabinoids CBs synthetics mixtures receptors agonists JWHs AMs 100.564303915699
11337 Synthetic Cannabinoid HPLC Mixture V (AM Series) New - ≥95% for each compound 2012-02-02 40.873690480371 synthetic-cannabinoid-hplc-mixture-v-am-series AM series AM-2201 AM-1220 AM-630 AM-1241 AM-694 AM-2233 AM2201 AM1220 AM630 AM1241 AM694 CBs cannbinoids mixtures AM2233 40.873690480371
10005440 Tafluprost 209860-87-7 >98% 2004-10-05 112.540037390479 tafluprost AFP-168 eyes glaucoma prostaglandins agonists FP receptors ophthalmology ophthalmological intraocular acids 17-phenyl trinor-PGF2.alpha. 17-phenyl trinor-PGF2alpha 15-deoxy-15,15-difluoro PGF analogs 16-phenoxy hypotensive 112.540037390479
10005439 Tafluprost (free acid) 209860-88-8 >98% 2004-09-22 87.907304218188 tafluprost-free-acid AFP-172 eyes glaucoma prostaglandins agonists FP receptors ophthalmology ophthalmological intraocular AFP172 hypotensives pressure IOP 87.907304218188
11629 Tamoxifen (citrate) New 54965-24-1 ≥98% 2012-04-04 71.420949142938 tamoxifen-citrate ICI 46474; Nolvadex; Istubal; Noltam; Kessar; TMX; Valodex; Zemide 7244-97-5 I.C.I.46474 citrate tamofen tamoplex tamox-puren tomaxasta Z-tamoxifen citrate nourytam ICI-46474 ICI46474 estrogen receptors cancers breasts agonists antagonists cholesterol modulators ER adjuvants bones uterus tissues cytochromes P450 CYP450 endoxifen cells apotosis autophagy differentiation 71.420949142938
10011348 Taprostene (free acid) Exclusive 108945-35-3 ≥95% ✓ 2009-11-11 43.647412523020 taprostene-free-acid CG 4203; Rheocyclan prostacyclins PGI2 receptors IP IP1 EP4 vascular smooth muscles relaxation analogs potential antagonists tissues preparations CG-4203 CG4203 SE63 SE-63 SE 63 43.647412523020
11615 Telmisartan New 144701-48-4 ≥98% 2012-05-09 89.077747084100 telmisartan Pritor; BIBR 277; Micardis BIBR 277SE BIBR277 BIBR-277 receptors antagonists blood pressure hypertension PPAR PPARγ atherosclerosis cardiovascular disease angiotensin hormones hearts myocardial infarction hypertrophy renal glomerulosclerosis 89.077747084100
19030 Thromboxane B2 54397-85-2 ≥99% 103.580638428483 thromboxane-b2 TXB2 thromboxanes platelets metabolites TXB2 intrarenal TXA2 urine urinary atherosclerosis 103.580638428483
10162 Treprostinil 81846-19-7 >98% 2005-08-30 75.237668508287 treprostinil Remodulin® primary pulmonary hypertension PPH arterial vascular resistance stable analogs prostacyclins increase plasma half-life vasodilatory inhibits inflammatory cytokines inhibition inhibitors GM-CF human alveolar macrophages NF-KB NF-.kappa. translocations nucleus NF-kappaB nfkb nf-kb NF-.kappa.B atherosclerosis Tyvasos Tyvaso® 75.237668508287
16440 U-44069 56985-32-1 >98% 235.746519337017 u-44069 9,11-dideoxy-9α,11α-epoxymethano Prostaglandin F2α; 9,11-dideoxy-9α,11α-epoxymethano PGF2α; 9,11-epoxymethano Prostaglandin H2 endoperoxides methanoepoxy PGH2 thromboxanes analogs prostaglandins U44069 TP receptors agonists atherosclerosis 235.746519337017
16450 U-46619 56985-40-1 >98% 225.073822199899 u-46619 9,11-dideoxy-9α,11α-methanoepoxy Prostaglandin F2α; 9,11-dideoxy-9α,11α-methanoepoxy PGF2α endoperoxides PGH2 thromboxanes vasoconstriction analogs TP receptors agonists U46619 atherosclerosis 225.073822199899
10010522 U-46619 Glycine methyl ester - >98% 2008-03-24 110.487127071823 u-46619-glycine-methyl-ester TP receptors agonists inflammations PGH2 endoperoxides thromboxanes vasoconstriction analogs U46619 3 prodrugs forms 110.487127071823
13261 URB447 Exclusive 1132922-57-6 ≥98% ✓ 2009-06-18 35.040220994475 urb447 CB1 CB2 cannabinoids antagonists obesity SR 141716A SR141716A rimonabant blood brains barrier URB appetite suppressant receptors URB-447 URB blocking peptides 447 cannabinoids cbs synthetic 35.040220994475
10790 Xanomeline oxalate 141064-23-5 ≥98% 2011-06-14 0.443784530386 xanomeline-oxalate Lumeron; Memcor; LY246708 agonists muscarinic receptors acetylcholine psychosis antipsychotic memory neurotransmitters neurological Alzheimer’s diseases M1-preferring 0.443784530386
13673 ZK118182 isopropyl ester Exclusive 154927-31-8 ≥98% ✓ 2010-11-05 0.845303867403 zk118182-isopropyl-ester intraocular pressure IOP glaucoma PGD2 agonists DP receptors hypertension Hexadecanoylcarnitine Palmitoylcarnitine Palmitylcarnitine 0.845303867403
10445 α-Pyrrolidinopropiophenone (hydrochloride) Exclusive 92040-10-3 ≥97% ✓ 2011-08-24 39.228669052402 -pyrrolidinopropiophenone-hydrochloride ɑ-PPP designer drugs forensics analogs diethylcathinone Wistar rats cathinone appetite suppressants PPP MPPP MDPPP αPPP alphaPPP alpha-pyrrolidinopropiophenone 19134-50-0 a-PPP aPPP a PPP 39.228669052402
18550 Δ12-Prostaglandin J2 87893-54-7 ≥95% 62.919779005524 -12-prostaglandin-j2 Δ12-PGJ2 delta12-PGJ2 d12-PGJ2 .DELTA.12-PGJ2 antitumor antimitotic PPARgamma PPAR.gamma. PPARs peroxisome proliferator-activated receptors prostaglandins ligands 62.919779005524
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?